573 related articles for article (PubMed ID: 26778511)
1. Management of moyamoya syndrome in patients with Noonan syndrome.
Gupta M; Choudhri OA; Feroze AH; Do HM; Grant GA; Steinberg GK
J Clin Neurosci; 2016 Jun; 28():107-11. PubMed ID: 26778511
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
3. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
4. "Recycling" A Failed Superficial Temporal Artery Indirect Bypass into a Double Barrel Direct Bypass in Moyamoya Disease.
Yearley AG; Bernstock JD; Kappel AD; Chen JA; Torio E; Gupta S; Lai PMR; Patel NJ
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106581. PubMed ID: 35661544
[TBL] [Abstract][Full Text] [Related]
5. Moyamoya syndrome in a child with Noonan syndrome.
Hung PC; Wang HS; Wong AM
Pediatr Neurol; 2011 Aug; 45(2):129-31. PubMed ID: 21763956
[TBL] [Abstract][Full Text] [Related]
6. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
8. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.
Nagata S; Matsushima T; Morioka T; Matsukado K; Mihara F; Sasaki T; Fukui M
Neurosurgery; 2006 Oct; 59(4):830-6; discussion 836-7. PubMed ID: 17038947
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
Fujimura M; Kaneta T; Shimizu H; Tominaga T
Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
[TBL] [Abstract][Full Text] [Related]
10. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
12. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review.
Kazumata K; Ito M; Tokairin K; Ito Y; Houkin K; Nakayama N; Kuroda S; Ishikawa T; Kamiyama H
J Neurosurg; 2014 Aug; 121(2):432-40. PubMed ID: 24605834
[TBL] [Abstract][Full Text] [Related]
13. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
[TBL] [Abstract][Full Text] [Related]
14. Transient crossed cerebellar diaschisis due to cerebral hyperperfusion following surgical revascularization for moyamoya disease: case report.
Hokari M; Kuroda S; Simoda Y; Uchino H; Hirata K; Shiga T; Nakayama N; Houkin K; Tamaki N
Neurol Med Chir (Tokyo); 2012; 52(5):350-3. PubMed ID: 22688075
[TBL] [Abstract][Full Text] [Related]
15. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.
Thines L; Petyt G; Aguettaz P; Bodenant M; Himpens FX; Lenci H; Henon H; Gauthier C; Hossein-Foucher C; Cordonnier C; Lejeune JP
Rev Neurol (Paris); 2015 Jan; 171(1):31-44. PubMed ID: 25555850
[TBL] [Abstract][Full Text] [Related]
19. Noonan syndrome and moyamoya.
Ganesan V; Kirkham FJ
Pediatr Neurol; 1997 Apr; 16(3):256-8. PubMed ID: 9165521
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
